By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ferring Pharmaceuticals 

Avenue de Rhodanie 60

Lausanne    CH 1007  Switzerland
Phone: 41-21-614-2772 Fax: 41-21-614-2773



Company News
Ferring Pharma Announces Exclusive Agreement With Alrise Biosystems For The Development Of An Injectable, Controlled-Release Peptide 4/10/2017 6:11:46 AM
Ferring Pharma Highlights Progress On Social And Environmental Goals In Corporate Social Responsibility (CSR) Review 2015-2016 4/6/2017 8:15:20 AM
Ferring Pharma And CDI Sign Agreement Granting Ferring Exclusive Marketing Rights To VSL#3 In Europe And Canada 3/20/2017 6:14:32 AM
Ferring Pharma: Waking Up To Go To The Toilet Is The Number One Cause Of A Poor Night’s Sleep, Say Experts On World Sleep Day 3/17/2017 6:19:20 AM
Ferring Pharma Collaborates With ICF On Development Of A Potential New Treatment For Anal Fissures With A Focus On Improving Quality Of Care For IBD Patients 3/15/2017 8:31:47 AM
Ferring Pharma Announces Recipients Of Innovation Grants Program 2016-2017 2/15/2017 8:05:26 AM
Ferring Pharma And Foresee Pharma Enter Into Exclusive Development And Option Agreement 2/13/2017 7:01:49 AM
Ferring Pharma And Enteris Biopharma Enter License Agreement To Develop An Oral Formulation Of A Peptide-Based Injectable Therapeutic 1/30/2017 6:42:43 AM
Ferring Pharma Partners With Intralytix To Develop Bacteriophage Treatments For Conditions Associated With The Microbiome And Drug-Resistant Bacteria 1/9/2017 10:51:00 AM
Ferring Pharma And IMAB Sign Licensing Agreement Granting IMAB Exclusive Rights In Asia To Olamkicept For The Treatment Of Autoimmune Disease 12/19/2016 10:22:19 AM